Furthermore, ELK1 inhibits SYVN1-mediated PS1 ubiquitination and degradation, leading to increased γ-secretase activity and Aβ production, highlighting the potential regulatory role of SYVN1 in AD pathogenesis (Fig. 3). Here, ELK1 is linked to Alzheimer disease.